Health
Comparison of oral vs intravenous etoposide in the management of small‐cell lung cancer: A real‐world, population‐based study – MD Linx
MDLinx original journal summary on Lung Cancer, Pulmonology from The Clinical Respiratory Journal
For firstline treatment in smallcell lung cancer (SCLC), researchers assessed whether PO vs IV etoposide is useful in combination with a platinum agent (cisplatin/carboplatin) in this study including 2,066 patients with SCLC. Based on stage, patients were divided as limited disease and extensive disease. Route of etoposide administration, dose reductions and vital status was evaluated in chemotherapy naïve patients receiving one cycle of combination chemotherapy. Findings revealed similar overal…
-
Noosa News22 hours agoTrump’s trade war puts Australian beef centre stage in Shanghai
-
General22 hours agoCoomalie council dismissed by NT government after investigation finds ‘serious deficiencies’
-
Noosa News21 hours agoHuge suburban crowd cheers for luxury house sale at sausage sizzle auction
-
General23 hours agoGrain growers face costly nightmare of ‘clumped’ fertiliser